All Stories

  1. Isolation and Characterization of Nuciferoic Acid, a Novel Keto Fatty Acid with Hyaluronidase Inhibitory Activity from Cocos nucifera Linn. Endocarp
  2. Preventive and Therapeutic Potentials of Anthocyanins in Diabetes and Associated Complications
  3. Association of Metronidazole with Cancer: A Potential Risk Factor or Inconsistent Deductions?
  4. Marine Drugs: A Hidden Wealth and a New Epoch for Cancer Management
  5. In silico Structure-based Identification of Novel Acetylcholinesterase Inhibitors Against Alzheimer’s Disease
  6. Inhibition of Proliferation and Induction of Apoptosis by Thymoquinone via Modulation of TGF Family, p53, p21 and Bcl-2α in Leukemic Cells
  7. Molecular interaction and computational analytical studies of Pinocembrin for its antiangiogenic potential targeting VEGFR-2: A persuader of metastasis
  8. The use of Azoles Containing Natural Products in Cancer Prevention and Treatment: An Overview
  9. Editorial (Thematic Issue: Managing Strategies for Diverse Diseases: Challenges from Bench to Bedside Translation in Successful Drug Discovery and Dev elopment (Part C))
  10. Editorial (Thematic Issue: Managing Strategies for Diverse Diseases: Challenges from Bench to Bedside Translation in Successful Drug Discovery and Development)
  11. Pharmacophore-Based Virtual Screening for Identification of Novel Neuraminidase Inhibitors and Verification of Inhibitory Activity by Molecular Docking
  12. An Overview of Current Screening and Management Approaches for Prostate Cancer
  13. Global Trends in Nanotechnology For Health Issues
  14. Nanotechnology-based inhalation treatments for lung cancer: state of the art
  15. Determination of potential role of antioxidative status and circulating biochemical markers in the pathogenesis of ethambutol induced toxic optic neuropathy among diabetic and non-diabetic patients
  16. Editorial (Thematic Issue: Global Trends for Nanotechnological Approaches in Various Health Issues - Part 1)
  17. In silico Screening for Identification of Novel Anti-malarial Inhibitors by Molecular Docking, Pharmacophore Modeling and Virtual Screening
  18. Meet Our Editors
  19. Meet Our Editorial Board Member:
  20. Combination of selenium-enriched green tea polysaccharides and Huo-ji polysaccharides synergistically enhances antioxidant and immune activity in mice
  21. Observations on the expression of human papillomavirus major capsid protein in HeLa cells
  22. Current Update on Synopsis of miRNA Dysregulation in Neurological Disorders
  23. Meet the Editorial Board
  24. Correlation of Toll-Like Receptor 4, Interleukin-18, Transaminases, and Uric Acid in Patients With Chronic Periodontitis and Healthy Adults
  25. The role of epigenetics in personalized medicine: challenges and opportunities
  26. Assessment of the role of general, biochemical and family history characteristics in kidney stone formation
  27. Prevalence of multidrug resistant and extended spectrum beta-lactamase producing Pseudomonas aeruginosa in a tertiary care hospital
  28. The association of nutritional profile and prognosis of degenerative diseases associated with carbohydrate and lipid metabolism at high altitude of district Ziarat, Pakistan
  29. Risk factors for acquisition of extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae in North-Indian hospitals
  30. Reduction of post-prandial hyperglycemia by mulberry tea in type-2 diabetes patients
  31. Treatment of psoriasis by using Hijamah: A case report
  32. Biological aspect of various global health issues
  33. Medicinal Plants in Management of Type 2 Diabetes and Neurodegenerative Disorders
  34. Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment
  35. Assessment of circulating biochemical markers and antioxidative status in acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) patients
  36. Small Molecules from Nature Targeting G-Protein Coupled Cannabinoid Receptors: Potential Leads for Drug Discovery and Development
  37. Editorial (Thematic Issue: Linkage of Neurodegenerative Disorders with Other Health Issues – Volume II)
  38. Quinoline Derivatives: Candidate Drugs for a Class B G-Protein Coupled Receptor, the Calcitonin Gene-Related Peptide Receptor, a Cause of Migraines
  39. Computational Study of Human Tyrosine Hydroxylase Mutants to Uphold [4-(Propan-2-yl) Phenyl]Carbamic Acid as a Potential Inhibitor
  40. Editorial (Thematic Issue: Linkage of Neurodegenerative Disorders with Other Health Issues – Volume I)
  41. Panacea seed “Nigella”: A review focusing on regenerative effects for gastric ailments
  42. Recent Updates in the Treatment of Neurodegenerative Disorders Using Natural Compounds
  43. Candida identification: a journey from conventional to molecular methods in medical mycology
  44. Dear Global Researchers in the disciple of Genetics, Molecular, Cellular Biology and related sciences
  45. Hepatoprotective Effects ofSilybum marianum(Silymarin) andGlycyrrhiza glabra(Glycyrrhizin) in Combination: A Possible Synergy
  46. Link between Cancer and Alzheimer Disease via Oxidative Stress Induced by Nitric Oxide-Dependent Mitochondrial DNA Overproliferation and Deletion
  47. An Overview on Potential Neuroprotective Compounds for Management of Alzheimer’s Disease
  48. Cancer Chemoprevention by Polyphenols and Their Potential Application as Nanomedicine
  49. Nanotechnology-based approaches in anticancer research
  50. Editorial [Hot Topic: Status of Tyrosine Hydroxylase in the Healthy and Parkinson's Brain (Guest Editor: Mohammad Amjad Kamal)]
  51. Butyrylcholinesterase inhibitors modulate cytokines production in peripheral blood mononuclear cells
  52. Sensitivity of bovine retinal acetylcholinesterase to phenserine: A derivative of physostigmine
  53. Acetylcholinesterase inhibition by diazinon: A dual substrate model for kinetic study
  54. Investigation of the effect of lannate on kinetic parameters of acetylcholinesterase: Slightly concave mixed-type of inhibition system
  55. Dual temperature model for the estimation of energetics parameters for acetylcholinesterase inhibition by cyclophosphamide
  56. Effect of malathion on kinetic parameters of acetylcholinesterase (EC 3.1.1.7)In vitro
  57. Effect of sevin on kinetic parameters of camel retina acetylcholinesterase
  58. The inhibitory effect of cyclophosphamide on camel retina acetylcholinesterase activity
  59. The Mode of Inhibition of Human Erythrocyte Membrane-Bound Acetylcholinesterase by Cisplatinin Vitro